• Investing replay

    HEDGEYE INVESTING SUMMIT

    SPECIAL HEDGEYE TV EVENT

    The sharpest minds in investing discuss the most important market and economic developments and their investing implications.
    Watch the free replay.

Below is a complimentary excerpt from an institutional research note written by our Cannabis analysts Howard Penney and Daniel BiolsiIf you are an institutional investor interested in accessing our research email sales@hedgeye.com

Florida’s Medical Marijuana Marketplace Has Strong Potential  - 8 10 2020 12 31 41 PM

For the week ending August 7th, the number of qualified patients in Florida’s medical marijuana program grew 1.8% WoW or 30% YTD.

The WoW increase to 389,235 qualified patients at 1.8% was the greatest sequential increase in the last 12-months.

THC in mgs sold fell -1.6% WoW to 132.3 million mgs, CBD in mgs sold fell -0.2% WoW to 3.87 million mgs, flower in oz. sold grew 2.0% WoW to 41,197 oz. sold.

Trulieve (TCNNF) continues its market dominance with a 51% share of mgs THC sold, 32% share of mgs CBD sold, and 51% of flower in oz. sold, while holding only ~20% of market share in units, on a 4-week moving average basis.

Florida’s medical marijuana marketplace is still in early stages with strong potential – the state’s medical marijuana program has yet to reach 2% of the population, smokable flower was just introduced to the market last year, and there’s a broad range of qualifying medical conditions, notably ‘severe and chronic pain’.

The rising tide that is patient volume growth lifts all ships.

Florida’s Medical Marijuana Marketplace Has Strong Potential  - lk

Florida’s Medical Marijuana Marketplace Has Strong Potential  - lk1